Literature DB >> 11829192

Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma.

J Klatka1.   

Abstract

Previous studies have yielded inconsistent results on the prognostic significance of p53 and bcl-2 in head and neck cancer. The aim of this study was the evaluation of p53 and bcl-2 protein expression in laryngeal squamous cell carcinoma and to clarify the relationship between them. All patients with laryngeal carcinoma were treated during the period 1991-1993. In the present study p53 and bcl-2 expression in paraffin sections from 50 cases of laryngeal squamous cell carcinoma were analysed and correlated with routine clinico-pathological parameters. The expressions of p53 and bcl-2 were examined by immunohistochemical staining. Immunoreactivity for p53 was observed in 45 (90%) of carcinomas and bcl-2 immunoreactivity in 7 (14%). No significant correlation between the p53 or bcl-2 expression and patients' T- or N-stage, histological grading, or overall survival was found.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11829192     DOI: 10.1007/s004050100383

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  3 in total

1.  Possible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma.

Authors:  Marcela K Hassumi-Fukasawa; Fabiana A Miranda-Camargo; Márcia C M Guimarães; Renata T Simões; Eduardo A Donadi; Christiane P Soares; Edson G Soares
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-02-05       Impact factor: 2.503

2.  p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.

Authors:  D Mielcarek-Kuchta; J Olofsson; W Golusinski
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-09       Impact factor: 2.503

3.  Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma.

Authors:  William A Michaud; Anthony C Nichols; Edmund A Mroz; William C Faquin; John R Clark; Shahnaz Begum; William H Westra; Hiroshi Wada; Paul M Busse; Leif W Ellisen; James W Rocco
Journal:  Clin Cancer Res       Date:  2009-02-24       Impact factor: 12.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.